Global
The African Markets Pharma Can't Ignore
In its new study on pharma market growth in Africa, IMS Health highlights three 'rising stars' from the continent's sub-Saharan region that are set to join the more established markets of South Africa, Algeria, Egypt, and Morocco as major countries to watch in the next five to 10 years ...Read more
Regulatory
Lilly Charged with Corruption Abroad: A Taste of Fines to Come?
The Securities and Exchange Commission filed charges at the end of December on Eli Lilly and Co. for violations of the Foreign Corrupt Practices Act (FCPA) that allege the drug maker's subsidiaries overseas bribed foreign officials in Russia, China, Brazil and Poland ...Read More
Event
The First — and Last — Word on Medication Adherence: Keep Trying!
Patient adherence to medicine is the eternal puzzle for Big Pharma: what combinations of financial incentives, personalized interventions, and just good information work best to push down that stubborn 50 per cent abandonment threshold after six months of treatment? Ahead of the Patient Adherence Awards in Philadelphia in April, Robert Nauman assesses the current and future state of medication adherence ...Read more
Europe
EMA Announces 2013 Plans
The European Medicines Agency promises to increase operational efficiency, enhance transparency and communication with stakeholders, and improve the quality and consistency of rulemaking in 2013 ...Read more |
